Patents by Inventor Christopher Akinleye Alabi

Christopher Akinleye Alabi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sequence-defined polymers and methods of making same and using same
    Patent number: 11384205
    Abstract: Methods of making sequence-defined polymers and sequence-defined polymers. The methods are based on the orthogonal reactivity of monomers having at least two different functional groups. The sequence-defined polymers can be used in various applications. For example, the SDPs (e.g., pH sensitive SDPs) are used in cell lysis methods or as molecular vehicles to transport drug cargo into cells.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: July 12, 2022
    Assignee: CORNELL UNIVERSITY
    Inventors: Christopher Akinleye Alabi, Mintu Porel
  • SYSTEMS AND METHODS FOR INTRACELLULAR DELIVERY VIA NON-CHARGED SEQUENCE-DEFINED CELL-PENETRATING OLIGOMERS
    Publication number: 20210308270
    Abstract: The present disclosure provides oligoTEAs and methods of using the oligoTEAs. The oligoTEAs may be functionalized with one or more cargo group. The oligoTEAs may be made by iterative thiol-ene and Michael reactions. The oligoTEAs functionalized with one or more cargo group may be used to treat bacterial infections, cancers, viral infections, urinary tract infections, skin infections, cystic fibrosis, sepsis, fungal infections, or a combination thereof.
    Type: Application
    Filed: May 16, 2019
    Publication date: October 7, 2021
    Inventors: Christopher Akinleye ALABI, Ngoc Nhu PHAN
  • OLIGOTHIOETHERAMIDES (OLIGOTEAS) AS ANTI-MICROBIAL AND ANTI-BACTERIAL AGENTS
    Publication number: 20200361861
    Abstract: Provided are oligothioetheramides (oligoTEAs) having a plurality of cationic groups, such as, for examples, cationic groups having guanidinium groups. The cationic oligoTEAs exhibit activity against gram-positive and gram-negative bacteria. The compounds can be used as antibacterial compounds against the same.
    Type: Application
    Filed: August 17, 2018
    Publication date: November 19, 2020
    Inventors: Christopher Akinleye ALABI, Ngoc Nhu PHAN
  • SEQUENCE-DEFINED POLYMERS AND METHODS OF MAKING SAME AND USING SAME
    Publication number: 20200299461
    Abstract: Methods of making sequence-defined polymers and sequence-defined polymers. The methods are based on the orthogonal reactivity of monomers having at least two different functional groups. The sequence-defined polymers can be used in various applications. For example, the SDPs (e.g., pH sensitive SDPs) are used in cell lysis methods or as molecular vehicles to transport drug cargo into cells.
    Type: Application
    Filed: December 10, 2019
    Publication date: September 24, 2020
    Inventors: Christopher Akinleye Alabi, Mintu Porel
  • Sequence-defined polymers and methods of making same and using same
    Patent number: 10501581
    Abstract: Methods of making sequence-defined polymers and sequence-defined polymers. The methods are based on the orthogonal reactivity of monomers having at least two different functional groups. The sequence-defined polymers can be used in various applications. For example, the SDPs (e.g., pH sensitive SDPs) are used in cell lysis methods or as molecular vehicles to transport drug cargo into cells.
    Type: Grant
    Filed: August 19, 2015
    Date of Patent: December 10, 2019
    Assignee: Cornell University
    Inventors: Christopher Akinleye Alabi, Mintu Porel
  • SEQUENCE-DEFINED POLYMERS AND METHODS OF MAKING SAME AND USING SAME
    Publication number: 20160075831
    Abstract: Methods of making sequence-defined polymers and sequence-defined polymers. The methods are based on the orthogonal reactivity of monomers having at least two different functional groups. The sequence-defined polymers can be used in various applications. For example, the SDPs (e.g., pH sensitive SDPs) are used in cell lysis methods or as molecular vehicles to transport drug cargo into cells.
    Type: Application
    Filed: August 19, 2015
    Publication date: March 17, 2016
    Inventors: Christopher Akinleye Alabi, Mintu Porel